NRS invested in ReDA which not only addresses the need for a united data source, it also provides a robust approach to clinical trial management. In particular, it gives NRS valuable clarity in terms of Key Performance Indicators like approval times.
“We run the full spectrum of clinical trials. Having a united data source for the entirety of clinical research going on in Scotland provides invaluable Management Information.”